OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-55 Cr | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-9.59 Cr |
| Mar2023 | ₹-7.89 Cr |
| Mar2022 | ₹1.50 Cr |
| Mar2021 | ₹-1.55 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-9.59 Cr | Negative | |
| Mar2023 | ₹-7.89 Cr | Negative | |
| Mar2022 | ₹1.50 Cr | Positive | |
| Mar2021 | ₹-1.55 Cr | - | |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹182.7 Cr | -2% | 3.2% | -55.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -2% |
3.2% |
-55.2% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses